Mergers and Acquisitions 6 January 2026

Eldorado Gold stock sinks on Foran Mining buyout: what investors watch next

Eldorado Gold shares dropped Monday following the announcement of a deal to acquire Foran, expanding its copper portfolio and adding a near-term development project. The New York-listed stock fell $4.03 to $38.89, having earlier dipped to $36.40.

2 February 2026

Mergers and Acquisitions·Mining Industry·NYSE:EGO·NYSE:GOLD·NYSE:NEM·Stock Market·TSX:FOM

Beazley share price steadies, but Zurich bid clock keeps traders on edge heading into Monday

Beazley shares closed Friday at 1,133 pence, edging up 0.09% in a quiet session that failed to close in on a potential takeover bid.

31 January 2026

LSE:BEZ·Mergers and Acquisitions·Stock Market·SWX:ZURN

Abbott stock rebounds as Exact Sciences vote nears after broker upgrade

Abbott Laboratories shares climbed roughly 2.6%, closing in on $108.89 Friday afternoon after earlier dipping to $105.72. The stock hit a peak of $109.34 during the session.

30 January 2026

Mergers and Acquisitions·NASDAQ:EXAS·NYSE:ABT·Stock Market

Coeur Mining (CDE) slides as silver ETF rush collides with New Gold deal vote

Shares of Coeur Mining, Inc. fell about 2.5% to $24.81 on Tuesday, after swinging between $24.06 and $26.14 earlier in the session. The stock last closed at $25.45.

27 January 2026

ETFs·Mergers and Acquisitions·Mining Industry·NYSE:CDE·NYSE:HL·TSX:NGD

Beazley share price in focus as Zurich’s bid clock ticks toward Feb. 16 — what London traders watch

Beazley Plc shares look poised for more takeover talk in London on Monday, having closed at 1,152 pence on Friday—a 3.23% rise.

26 January 2026

Mergers and Acquisitions·Stock Market

Beazley shares rise again as Zurich bid deadline nears — what to watch when London reopens

Beazley Plc shares ended Friday 3.23% higher at 11.52 pounds, outpacing a flat London market. Investors remained focused on the Zurich takeover saga heading into the weekend.

24 January 2026

LSE:BEZ·Mergers and Acquisitions·Stock Market·SWX:ZURN

Kenvue (KVUE) stock price barely budges as Kimberly-Clark deal vote nears

Kenvue Inc shares edged up 0.1% to $17.77 on Friday, tracking closely with a flat tape and a small dip in would-be buyer Kimberly-Clark.

23 January 2026

Mergers and Acquisitions·NYSE:KMB·NYSE:KVUE·Stock Market

Netflix flips to an all-cash $82.7 billion Warner Bros. Discovery bid as Paramount clock ticks

Netflix has shifted to an all-cash bid for Warner Bros. Discovery’s studio and streaming units, keeping the price steady at $82.7 billion in a move to edge out Paramount Skydance. The updated offer would pay Warner shareholders $27.75 per share, according to a filing on Tuesday.

20 January 2026

Mergers and Acquisitions·NASDAQ:NFLX·NASDAQ:PARA·NASDAQ:WBD

Kenvue stock edges up as Kimberly-Clark vote nears — the deal spread traders are watching

Kenvue Inc shares ticked up roughly 0.4% to $17.08 on Wednesday, continuing a stretch of modest fluctuations as the stock moves mainly on deal speculation. The gain followed Kimberly-Clark’s submission of extra documents to the U.S. Securities and Exchange Commission related to its intended purchase of the consumer health firm.

14 January 2026

Mergers and Acquisitions·NYSE:KMB·NYSE:KVUE·Stock Market

Netflix stock slips as all-cash Warner Bros bid talk swirls, with earnings days away

Netflix shares dropped 1.6% Wednesday morning amid new developments in its pursuit of Warner Bros Discovery’s studio and streaming units. Warner Bros stock held steady, while Paramount Skydance slipped roughly 0.6%.

14 January 2026

Earnings Reports·Mergers and Acquisitions·NASDAQ:NFLX·NASDAQ:PARA·NASDAQ:WBD

Glencore stock steady as Rio Tinto lines up banks for possible takeover

Glencore plc held steady at 470.2 pence in early London trading Wednesday, reflecting last week’s takeover rumors already baked into the price.

14 January 2026

LSE:GLEN·LSE:RIO·Mergers and Acquisitions·Mining Industry·Stock Market

Amphenol stock rises as Barclays, Citi and Truist lift targets after CommScope deal closes

Amphenol Corp shares climbed 2.2%, hitting $148.28 in afternoon trading Tuesday, defying the broader market slump. The S&P 500 ETF SPY and the tech-focused QQQ both slipped roughly 0.4%.

13 January 2026

Mergers and Acquisitions·NASDAQ:COMM·NYSE:APH·Stock Market

GSK stock in focus: JPMorgan healthcare agenda, merger chatter and key dates for investors

Shares of GSK plc edged down 0.03% to 1,885.5 pence early Monday in London, after fluctuating between 1,870.5 and 1,885.5 pence during the session.

12 January 2026

LSE:GSK·Mergers and Acquisitions·NYSE:GSK·Pharmaceuticals·Stock Market

Merck stock dips after $32 billion Revolution Medicines talks report, with Gardasil and Keytruda in focus

Merck & Co shares slipped on Friday following reports that the pharma giant is in talks to acquire cancer-focused biotech Revolution Medicines for as much as $32 billion. Merck ended the day down 0.4% at $110.53, after swinging between $110.26 and $112.46.

10 January 2026

Mergers and Acquisitions·NASDAQ:RVMD·NYSE:MRK·Pharmaceuticals·Stock Market

D-Wave Quantum stock (QBTS) slides after $550 million Quantum Circuits deal puts dilution in focus

D-Wave Quantum shares fell 3.4% to close at $30.20 on Wednesday after the quantum computing company announced a $550 million deal for Quantum Circuits. StockAnalysis

8 January 2026

Mergers and Acquisitions·NASDAQ:QBTS·Quantum Computing·Stock Market

Merck stock slips after Cidara tender offer; $9 billion R&D hit and HPV schedule shift in focus

Merck & Co shares were down about 0.3% at $108.59 in afternoon trade on Wednesday after the drugmaker said it had completed its cash tender offer for Cidara Therapeutics and expected to finish the acquisition through a merger later in the day. The company said the deal will be treated as an asset acquisition, lifting 2026 research and development expense by about $9.0 billion and cutting earnings per share by roughly 30 cents in the first 12 months. “The acquisition of Cidara strengthens and complements our expanding respiratory portfolio,” Chief Executive Robert M. Davis said. Merck.com

7 January 2026

Healthcare News·Mergers and Acquisitions·NASDAQ:CDTX·NYSE:MRK·Pharmaceuticals·Stock Market

Ventyx Biosciences stock jumps premarket as Eli Lilly buyout talks fuel takeover buzz

Ventyx Biosciences shares jumped about 66% before the bell on Wednesday after a report that Eli Lilly is in advanced talks to buy the biotech company for more than $1 billion. The stock traded at $16.70 in premarket action, versus a $10.05 regular-session close. Public

7 January 2026

Mergers and Acquisitions·NASDAQ:VTYX·NYSE:LLY·Stock Market

Gold.com stock steadies as Monex deal closes and gold prices hit a one-week high

Gold.com Inc shares were little changed on Tuesday, up less than 0.1% at $36.35 in early U.S. trading, after the precious-metals dealer confirmed it had closed its acquisition of Monex Precious Metals.

6 January 2026

Mergers and Acquisitions·Precious Metals·TSX:8698

US stock market: Vistra stock pops in premarket on $4.7B Cogentrix deal amid AI power-demand boom

Vistra shares were up 4.4% at $170.17 in premarket trading on Tuesday after the U.S. power producer said it would buy Cogentrix Energy from Quantum Capital Group in a deal valued at about $4.7 billion. TradingView+1

6 January 2026

Artificial Intelligence·Energy Sector·Mergers and Acquisitions·NYSE:VST

BlueScope Steel stock jumps 21% on A$30 takeover bid — the next catalyst investors are watching

BlueScope Steel Limited shares closed up 20.57% at A$29.48 on Tuesday after Australian conglomerate SGH and U.S. steelmaker Steel Dynamics confirmed an approach to buy the company for A$30 a share in cash. Investing.com+1

6 January 2026

ASX:BSL·Mergers and Acquisitions·NASDAQ:STLD·Stock Market

Mergers and Acquisitions 6 January 2026 - 2 February 2026